GREAT BASIN SCIENTIFIC INC (GBSN) financial statements (2021 and earlier)

Company profile

Business Address 420 E. SOUTH TEMPLE
SALT LAKE CITY, UT 84111
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0111257
Cash and cash equivalents0111257
Receivables0000000
Inventory, net of allowances, customer advances and progress billings1121111
Inventory1121111
Deferred costs00   0 
Other undisclosed current assets1848471515141
Total current assets:2051501719219
Noncurrent Assets
Property, plant and equipment1010109887
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Restricted cash and investments 1224    
Total noncurrent assets:1022349888
TOTAL ASSETS:29738326282917
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities101097443
Accounts payable5443322
Accrued liabilities5654211
Debt336128151011
Derivative instruments and hedges, liabilities  502135  
Due to related parties1111111
Other undisclosed current liabilities     2 
Total current liabilities:437187435075
Noncurrent Liabilities
Long-term debt and lease obligation01500011
Long-term debt, excluding current maturities 15   1 
Capital lease obligations0000011
Liabilities, other than long-term debt16435743214330
Financial instruments subject to mandatory redemption, settlement terms, share value, amount116     
Other liabilities 12    
Derivative instruments and hedges, liabilities5365643214330
Total noncurrent liabilities:16585744214531
Total liabilities:5912914587715236
Stockholders' equity
Stockholders' equity attributable to parent(30)(56)(61)(61)(43)(23)(19)
Preferred stock0000000
Common stock0000000
Additional paid in capital1601551431151129983
Accumulated deficit(190)(211)(205)(176)(156)(122)(103)
Total stockholders' equity:(30)(56)(61)(61)(43)(23)(19)
TOTAL LIABILITIES AND EQUITY:29738326282917

Income statement (P&L) ($ in millions)

3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
Revenues1111111
Cost of revenue(2)(2)(2)(2)(2)(1)(1)
Gross profit:(1)(1)(1)(1)(1)(1)(1)
Operating expenses(5)(8)(8)(8)(6)(6)(6)
Operating loss:(6)(9)(9)(9)(7)(7)(7)
Nonoperating income (expense)283(20)(11)(27)(12)20
Investment income, nonoperating00000(4)0
Interest and debt expense1(7)(17)(6)(6)(11)(0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(1)71766110
Income (loss) from continuing operations before income taxes:22(6)(29)(20)(34)(19)13
Income tax expense    (0)  
Net income (loss) available to common stockholders, basic:22(6)(29)(20)(34)(19)13
Other undisclosed net loss available to common stockholders, diluted(34)     (1)
Net income (loss) available to common stockholders, diluted:(12)(6)(29)(20)(34)(19)12

Comprehensive Income ($ in millions)

3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
Net income (loss):22(6)(29)(20)(34)(19)13
Comprehensive income (loss), net of tax, attributable to parent:22(6)(29)(20)(34)(19)13

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: